Rubella - Clinical trials 

  • Clinical trials

Clinical trials for Rubella

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Rubella. For all clinical trials, go to clinical trials search

This list shows clinical trials for Rubella

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Rubella
Title Recruitment status Location
Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children Not recruiting United Kingdom
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ dTpa-IPV vaccine (Boostrix Polio) compared with Sanofi Pasteur MSD’s dTpa-IPV vaccine (Repevax), when co-administered with GSK Biologicals’ MMR vaccine (Priorix) in 3 and 4-year-old healthy children. - DTPA-IPV (BOOSTRIX-IPV)-009 Authorised United Kingdom
Study of QUADRACEL® Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age Recruiting Puerto Rico
Study of QUADRACEL® Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age Recruiting United States
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants Recruiting Israel
Topical coating of measles-mumps-rubella vaccine for the treatment of respiratory papilloma Recruiting China
Ontogeny of Measles Immunity in Infants Recruiting United States
Investigation of incidence of measles, mumps and rubella in patients with inflammatory bowel disease Recruiting Japan
Sero-surveillance to assess rubella susceptibility including assessment of immunogenicity and safety of Rubella vaccine in females aged 18-24 years. Recruiting India
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children Recruiting Italy
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member